Flow-cytometric approach to the prompt laboratory diagnosis of TRALI: a case report

被引:7
|
作者
Porretti, L
Coluccio, E
Prati, D
Colombo, MB
Lopa, R
Tombolini, P
Ambrosone, A
Crespiatico, L
Scalamogna, M
Rebulla, P
机构
[1] IRCCS Osped Maggiore Policlin, Ctr Trasfus & Immunol Trapianti, I-20122 Milan, Italy
[2] IRCCS Osped Maggiore Policlin, Serv Autonomo Prelievo & Trapianto Organi & Tessu, Milan, Italy
[3] Osped A Manzoni, Dipartimento Med Trasfus & Ematol, Lecce, Italy
[4] Osped S Carlo, Unita Operat Complessa urol, Milan, Italy
关键词
transfusion-related acute lung injury (TRALI); human leukocyte antigen (HLA) class II;
D O I
10.1111/j.1600-0609.2004.00279.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: Transfusion-related acute lung injury (TRALI) is a rare but serious complication which can occur after transfusion of blood components. In this report we describe our flow-cytometry approach to the laboratory diagnosis of a case of TRALI in a recipient of fresh frozen plasma containing human leukocyte antigen (HLA) class II antibodies. Methods: The post-transfusion reaction work-up included the direct and indirect Granulocyte Immunofluorescence Test (GIFT) on the recipient's neutrophils collected before and after the reaction and on the serum from the recipient and from all implicated donors; flow-cytometry bead-based screening and identification assay for HLA class I and II antibodies in donor sera and flow cytometry cross-matching on T and B patient's lymphocytes. Finally, we investigated the reactivity of one donor serum, containing HLA class II antibodies, with the patient's neutrophils activated in vitro to induce expression of HLA class II. Results: We found an increased level of IgG bound on patient's granulocytes collected after TRALI, in the absence of detectable granulocyte and HLA class I antibodies in the five implicated donors. One of them showed HLA-DR 1 and -DR 51 antibodies, which determined a positive cross-match with patient's B lymphocytes and in vitro activated granulocytes. Both HLA class II antigens were present in the recipient and absent in the donor. Conclusions: In some pathological conditions, HLA class II antibodies can react with activated granulocytes expressing HLA-DR antigens, and activate TRALI reaction. HLA class II antibodies screening and flow cytometry cross-matching techniques should be added to the current diagnostic algorithm of TRALI.
引用
收藏
页码:295 / 299
页数:5
相关论文
共 50 条
  • [41] Prompt diagnosis and extraordinary survival from Naegleria fowleri meningitis: A rare case report
    Sood, A.
    Chauhan, S.
    Chandel, L.
    Jaryal, S. C.
    INDIAN JOURNAL OF MEDICAL MICROBIOLOGY, 2014, 32 (02) : 193 - 196
  • [42] Prompt Diagnosis and Treatment of Uterine Arcuate Artery Pseudoaneurysm: A Case Report and Review of Literature
    Sharma, Nidhi
    Ganesh, Deepa
    Devi, Lakshmi
    Srinivasan, Jayashree
    Ranga, Upasana
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2013, 7 (10) : 2303 - 2305
  • [43] Role of the clinical laboratory in myeloma IGD diagnosis: A case report
    Diaz Merino, M. S.
    Picazo Perea, M. P.
    Palma Fernandez, R.
    Castelero Agudo, G.
    De Rafael Gonzalez, E.
    Rodelgo Garcia, L.
    CLINICA CHIMICA ACTA, 2019, 493 : S216 - S216
  • [44] CHORIOCARCINOMA - CURRENT CONCEPT OF LABORATORY DIAGNOSIS AND THERAPY AND REPORT OF A CASE
    EPSTEIN, SM
    JOURNAL OF THE AMERICAN OSTEOPATHIC ASSOCIATION, 1961, 60 (09): : 723 - &
  • [45] Flow-cytometric vs. -morphologic assessment of remission in childhood acute lymphoblastic leukemia: a report from the Children’s Oncology Group (COG)
    Sumit Gupta
    Meenakshi Devidas
    Mignon L. Loh
    Elizabeth A. Raetz
    Si Chen
    Cindy Wang
    Patrick Brown
    Andrew J. Carroll
    Nyla A. Heerema
    Julie M. Gastier-Foster
    Kimberly P. Dunsmore
    Eric C. Larsen
    Kelly W. Maloney
    Leonard A. Mattano
    Stuart S. Winter
    Naomi J. Winick
    William L. Carroll
    Stephen P. Hunger
    Michael J. Borowitz
    Brent L. Wood
    Leukemia, 2018, 32 : 1370 - 1379
  • [46] Flow-cytometric vs. -morphologic assessment of remission in childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group (COG)
    Gupta, Sumit
    Devidas, Meenakshi
    Loh, Mignon L.
    Raetz, Elizabeth A.
    Chen, Si
    Wang, Cindy
    Brown, Patrick
    Carroll, Andrew J.
    Heerema, Nyla A.
    Gastier-Foster, Julie M.
    Dunsmore, Kimberly P.
    Larsen, Eric C.
    Maloney, Kelly W.
    Mattano, Leonard A., Jr.
    Winter, Stuart S.
    Winick, Naomi J.
    Carroll, William L.
    Hunger, Stephen P.
    Borowitz, Michael J.
    Wood, Brent L.
    LEUKEMIA, 2018, 32 (06) : 1370 - 1379
  • [47] PROPOSAL FOR THERAPEUTIC APPROACH BASED ON PROGNOSTIC FACTORS INCLUDING MORPHOMETRIC AND FLOW-CYTOMETRIC FEATURES IN STAGE-III-IV OVARIAN-CANCER
    WILS, J
    VANGEUNS, H
    BAAK, J
    CANCER, 1988, 61 (09) : 1920 - 1925
  • [48] Diagnosis of unexpected acute myeloid leukemia and chronic lymphocytic leukemia: A case report demonstrating the perils of restricted panels in flow cytometric immunophenotyping
    Xie, XY
    Filie, AC
    Jasper, GA
    Fukushima, PI
    Stetler-Stevenson, M
    CYTOMETRY, 2000, 42 (02): : 114 - 117
  • [49] Flow-cytometric MRD detection in pediatric T-ALL: a multicenter AIEOP-BFM consensus-based guided standardized approach
    Reiterova, Michaela
    Kohlscheen, Saskia
    Maglia, Oscar
    Sala, Simona
    Schumich, Angela
    Maurer-Granofszky, Margarita
    Faggin, Giovanni
    Scarparo, Pamela
    Varotto, Elena
    Sestakova, Zuzana
    Svec, Peter
    Feuerstein, Tamar
    Vernitsky, Helly
    Kuzilkova, Daniela
    Hrusak, Ondrej
    Buldini, Barbara
    Dworzak, Michael
    Brueggemann, Monika
    Gaipa, Giuseppe
    Kalina, Tomas
    AIEOP-BFM ALL Flow group
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2025,
  • [50] Mantle Cell Lymphoma with Flow Cytometric Evidence of Clonal Plasmacytic Differentiation: A Case Report
    Naushad, Hina
    Choi, William W. L.
    Page, Cynthia J.
    Sanger, Warren G.
    Weisenburger, Dennis D.
    Aoun, Patricia
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2009, 76B (03) : 218 - 224